Annals of Emergency Medicine
Volume 37, Issue 2 , Pages 181-188, February 2001

Efficacy, safety, and use of snake antivenoms in the United States☆☆

Presented at the North American Congress of Clinical Toxicology’s “Advances in the Management of Snakebite” Symposium, October 1999, La Jolla, CA.

  • Richard C. Dart, MD, PhD

      Affiliations

    • Rocky Mountain Poison and Drug Center, Denver Health Authority, and the Department of Surgery, Medicine and Pharmacy, University of Colorado Health Sciences Center, Denver, CO
  • ,
  • Jude McNally, RPh, ABAT

      Affiliations

    • Arizona Poison and Drug Information Center, University of Arizona, Tucson, AZ.

Received 25 August 2000; received in revised form 29 November 2000; accepted 5 December 2000.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr. Dart and Mr. McNally were clinical investigators in the trials of the experimental antivenom described in the text and were paid speakers in the symposium “Advances in the Management of Snakebite” that was sponsored by Savage Laboratories.

☆☆ Address for reprints: Richard C. Dart, MD, PhD, Rocky Mountain Poison and Drug Center, 1010 Yosemite Circle, Denver, CO 80230; 303-739-1100, fax 303-739-1119;,E-mail rdart@rmpdc.org .

PII: S0196-0644(01)65378-2

doi:10.1067/mem.2001.113372

Refers to article:

  • Out-of-hospital and interhospital management of crotaline snakebite

    Patrick E. McKinney
    Annals of Emergency Medicine February 2001 (Vol. 37, Issue 2, Pages 168-174)

  • Role of surgical intervention in the management of crotaline snake envenomation

    Edward L. Hall
    Annals of Emergency Medicine February 2001 (Vol. 37, Issue 2, Pages 175-180)

  • Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies

    Steven A. Seifert, Leslie V. Boyer
    Annals of Emergency Medicine February 2001 (Vol. 37, Issue 2, Pages 189-195)

  • Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 2. Guidelines for clinical management with crotaline fab antivenom

    Leslie V. Boyer, Steven A. Seifert, Jeffrey S. Cain
    Annals of Emergency Medicine February 2001 (Vol. 37, Issue 2, Pages 196-201)

Annals of Emergency Medicine
Volume 37, Issue 2 , Pages 181-188, February 2001